<header id=010979>
Published Date: 2021-11-07 06:23:55 EST
Subject: PRO/ALL> New in IJID (10): October 2021
Archive Number: 20211107.8699506
</header>
<body id=010979>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (10): OCTOBER 2021
**********************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: October 2021
Source: IJID [edited]
https://www.ijidonline.com/


Editorial
---------
Antimicrobial resistance, infection prevention and control, and conflict in the Middle East.
Collin SM.
Int J Infect Dis. 2021;111:326-327
https://doi.org/10.1016/j.ijid.2021.09.001

Coronavirus (COVID-19) collection
---------------------------------
Reviews
-------
Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis.
Cui LY, et al.
Int J Infect Dis. 2021;111:154-163
https://doi.org/10.1016/j.ijid.2021.08.017
https://www.ijidonline.com/article/S1201-9712(21)00649-4/fulltext

Clinical
--------
Low infectious risk of re-positive COVID-19 patients: a single-center study.
Liang L, et al.
Int J Infect Dis. 2021;111:5-9
https://doi.org/10.1016/j.ijid.2021.08.019

Ultrastructural evidence for vertical transmission of SARS-CoV.
Birkhead M, et al.
Int J Infect Dis. 2021;111:10-11
https://doi.org/10.1016/j.ijid.2021.08.020

SARS-CoV-2 variant of concern P.1 (gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, northeast Brazil, February 2021.
Nonaka CKV, et al.
Int J Infect Dis. 2021;111:47-54
https://doi.org/10.1016/j.ijid.2021.08.003

External validation and recalibration of the CURB-65 and PSI for predicting 30-day mortality and critical care intervention in multiethnic patients with COVID-19.
Elmoheen A, et al.
Int J Infect Dis. 2021;111:108-116
https://doi.org/10.1016/j.ijid.2021.08.027

Serum trace elements levels and clinical outcomes among Iranian COVID-19 patients.
Pour OB et al.
Int J Infect Dis. 2021;111:164-168
https://doi.org/10.1016/j.ijid.2021.08.053

Multisystem inflammatory syndrome (MIS): a multicentre retrospective review of adults and adolescents in South Africa.
van Heerden J, et al.
Int J Infect Dis. 2021;111:227-232
https://doi.org/10.1016/j.ijid.2021.08.042

Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
Bhanuprasad K, et al.
Int J Infect Dis. 2021;111:267-270
https://doi.org/10.1016/j.ijid.2021.08.037

Cycle threshold values are inversely associated with poorer outcomes in hospitalized patients with COVID-19: a prospective, observational cohort study conducted at a UK tertiary hospital.
Wright J, et al.
Int J Infect Dis. 2021;111:333-335
https://doi.org/10.1016/j.ijid.2021.08.022

Diagnostics
-----------
How to ab(use) a COVID-19 antigen rapid test with soft drinks.
Velavan TP, et al.
Int J Infect Dis. 2021;111:28-30
https://doi.org/10.1016/j.ijid.2021.08.023

Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits.
Yang J, et al.
Int J Infect Dis. 2021;111:233-241
https://doi.org/10.1016/j.ijid.2021.08.043

Treatment
---------
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study.
Bhushan S, et al.
Int J Infect Dis. 2021;111:281-287
https://doi.org/10.1016/j.ijid.2021.08.044

Pathophysiology and immunology
------------------------------
SARS-CoV-2 is localized in cardiomyocytes: a post-mortem biopsy case.
Nakamura Y, et al.
Int J Infect Dis. 2021;111:43-46
https://doi.org/10.1016/j.ijid.2021.08.015

Circulating MR-proADM levels, as indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients.
de Guadiana-Romualdo LG, et al.
Int J Infect Dis. 2021;111:211-218
https://doi.org/10.1016/j.ijid.2021.08.058

Vaccines
--------
The strength of association between pre- and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
Salvagno GL, et al.
Int J Infect Dis. 2021;111:65-67
https://doi.org/10.1016/j.ijid.2021.08.059

Side effects and perceptions following Sinopharm COVID-19 vaccination.
Saeed BQ, et al.
Int J Infect Dis. 2021;111:219-226
https://doi.org/10.1016/j.ijid.2021.08.013

Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose.
Claro F, et al.
Int J Infect Dis. 2021;111:261-266
https://doi.org/10.1016/j.ijid.2021.0070

Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of self-reporting database.
Sato K, et al.
Int J Infect Dis. 2021;111:310-312
https://doi.org/10.1016/j.ijid.2021.08.071

Epidemiology
------------
Prevalence of and factors associated with COVID-19 diagnosis in symptomatic patients followed in general practices in Germany between March 2020 and March 2021.
Jacob L, et al.
Int J Infect Dis. 2021;111:37-42
https://doi.org/10.1016/j.ijid.2021.08.010

Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severity.
Imai K, et al.
Int J Infect Dis. 2021;111:68-75
https://doi.org/10.1016/j.ijid.2021.08.026

Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam.
Vinh Chau NV, et al.
Int J Infect Dis. 2021;111:127-129
https://doi.org/10.1016/j.ijid.2021.0072

Seroprevalence and risk factors for SARS-CoV-2 infection in selected urban areas in Ethiopia, July 2020.
Tadesse EB, et al.
Int J Infect Dis. 2021;111:179-185
https://doi.org/10.1016/j.ijid.2021.08.028

Association of COVID-19 case-fatality rate with disease burden: an ecological analysis in Italy during the first wave.
Timelli L, et al.
Int J Infect Dis. 2021;111:186-189
https://doi.org/10.1016/j.ijid.2021.08.032

SARS-CoV-2 infections in 165 countries over time.
Louca S, et al.
Int J Infect Dis. 2021;111:336-346
https://doi.org/10.1016/j.ijid.2021.08.067
https://www.ijidonline.com/article/S1201-9712(21)00701-3/fulltext

The low contagiousness and new A958D mutation of SARS-CoV-2 in children: an observational cohort study.
Chen Y, et al.
Int J Infect Dis. 2021;111:347-353
https://doi.org/10.1016/j.ijid.2021.08.036

Public health
-------------
How COVID-19 highlighted the need for infection prevention and control measures to become central to the global conversation: experience from the conflict settings of the Middle-East.
El Mouallem R, et al.
Int J Infect Dis. 2021;111:55-57
https://doi.org/10.1016/j.ijid.2021.08.034

Predicting COVID-19 incidence in French hospitals using human contact network analytics.
Selinger C, et al.
Int J Infect Dis. 2021;111:100-107
https://doi.org/10.1016/j.ijid.2021.08.029

A Bayesian estimate of the early COVID-19 infection fatality ratio in Brazil based on a random seroprevalence survey.
Marra V, et al.
Int J Infect Dis. 2021;111:190-195
https://doi.org/10.1016/j.ijid.2021.08.016

Case reports
------------
Symptomatic bradycardia in COVID-19 hospitalized patients: a case series.
Amir M, et al.
Int J Infect Dis. 2021;111:1-4
https://doi.org/10.1016/j.ijid.2021.0068

Herpes zoster after COVID-vaccination.
van Dam CS, et al.
Int J Infect Dis. 2021;111:169-171
https://doi.org/10.1016/j.ijid.2021.08.048

Non-COVID-19 collection
-----------------------
Bacterial infections
--------------------
Bloodstream infections in the COVID-19 era: results from an Italian multicenter study.
Pasquini Z, et al.
Int J Infect Dis. 2021;111:31-36
https://doi.org/10.1016/j.ijid.2021.0065

The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.
Dirkx KKT, et al.
Int J Infect Dis. 2021;111:196-203
https://doi.org/10.1016/j.ijid.2021.08.060

Antimicrobial resistance: a challenge awaiting the post COVID-19 era.
Lobie TA et al.
Int J Infect Dis. 2021;111:322-325
https://doi.org/10.1016/j.ijid.2021.09.003

Population pharmacokinetics of meropenem in critically ill infant patients.
Yonwises W, et al.
Int J Infect Dis. 2021;111:58-64
https://doi.org/10.1016/j.ijid.2021.08.031

Sociodemographic factors and uncomplicated pyelonephritis in women aged 15-50 years: a nationwide Swedish cohort register study (1997-2018).
Sundquist K, et al.
Int J Infect Dis. 2021;111:117-123
https://doi.org/10.1016/j.ijid.2021.08.009

C-reactive protein to rule out complicated pneumococcal disease manifestations: a retrospective cohort study in adults with pneumococcal bacteraemia.
Serbée MJV, et al.
Int J Infect Dis. 2021;111:172-178
https://doi.org/10.1016/j.ijid.2021.08.011

Epidemiology and trends of infective meningitis in neonates and infants less than 3 months of age in Hong Kong.
Wong CH, et al.
Int J Infect Dis. 2021;111:288-294
https://doi.org/10.1016/j.ijid.2021.0025

Vertebral osteomyelitis in bacterial meningitis patients.
Sheybani F, et al.
Int J Infect Dis. 2021;111:354-359
https://doi.org/10.1016/j.ijid.2021.08.069

Tuberculosis
------------
Interferon gamma release assays for detection of latent _Mycobacterium tuberculosis_ in older Hispanic people.
Scordo J, et al.
Int J Infect Dis. 2021;111:85-91
https://doi.org/10.1016/j.ijid.2021.08.014

Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis.
Fu L, et al.
Int J Infect Dis. 2021;111:138-147
https://doi.org/10.1016/j.ijid.2021.08.055

Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study.
Shi W, et al.
Int J Infect Dis. 2021;111:313-321
https://doi.org/10.1016/j.ijid.2021.08.064

Viral infections
---------------
Intestinal microbiota profiles in infants with acute gastroenteritis caused by Rotavirus and Norovirus infection.
Xiong L, et al.
Int J Infect Dis. 2021;111:76-84
https://doi.org/10.1016/j.ijid.2021.08.024

Serotype and genotype diversity of dengue viruses circulating in India: a multicentre retrospective study involving virus research diagnostic laboratory network during 2018.
Alagarasu K, et al.
Int J Infect Dis. 2021;111:242-252
https://doi.org/10.1016/j.ijid.2021.08.045

Seroprevalence and associated risk factors of chikungunya, dengue and Zika in eight districts in Tanzania.
Mwanyika GO, et al.
Int J Infect Dis. 2021;111:271-280
https://doi.org/10.1016/j.ijid.2021.08.040

Prevalence and genotype distribution of human papillomavirus infection among 12 076 Iranian women.
Bitarafan F, et al.
Int J Infect Dis. 2021;111:295-302
https://doi.org/10.1016/j.ijid.2021.0071

Rubella epidemiology in the Central African Republic, 2015-2016 and molecular characterization of virus strains from 2008-2016.
Pagonendji MS, et al.
Int J Infect Dis. 2021;111:303-309
https://doi.org/10.1016/j.ijid.2021.08.050

HIV
---
Lung ultrasound effectively detects HIV-associated interstitial pulmonary disease.
Marggrander DT, et al.
Int J Infect Dis. 2021;111:204-210
https://doi.org/10.1016/j.ijid.2021.08.030

HIV-1 diagnosis using dried blood spots from patients in Kinshasa, DRC: a tool to detect misdiagnosis and achieve World Health Organization 2030 targets.
Barquín D, et al.
Int J Infect Dis. 2021;111:253-260
https://doi.org/10.1016/j.ijid.2021.08.035

Parasitic infections
--------------------
Development of an immunochromatographic point-of-care test for detection of IgG antibody in serodiagnosis of human trichinellosis.
Thanchomnang T, et al.
Int J Infect Dis. 2021;111:148-153
https://doi.org/10.1016/j.ijid.2021.08.056

Epidemiology
------------
Lower respiratory tract infection hospitalizations among American Indian/Alaska Native adults, Indian Health Service and Alaska Region, 1998-2014.
Bruce MG, et al.
Int J Infect Dis. 2021;111:130-137
https://doi.org/10.1016/j.ijid.2021.08.033

Public health
-------------
Impact of the World Antimicrobial Awareness Week on public interest between 2015 and 2020: A Google Trends analysis.
Keitoku K, et al.
Int J Infect Dis. 2021;111:12-20
https://doi.org/10.1016/j.ijid.2021.08.018

Vaccines and vaccine preventable infections
----------------------------------------
Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study.
Immink MM, et al.
Int J Infect Dis. 2021;111:21-27
https://doi.org/10.1016/j.ijid.2021.08.025

Severe chickenpox disease and seroprevalence in Sweden -- implications for general vaccination.
Widgren K, et al.
Int J Infect Dis. 2021;111:92-98
https://doi.org/10.1016/j.ijid.2021.08.012

Trend change of nasopharyngeal colonization with _Streptococcus pneumoniae_ and nontypeable _Haemophilus influenzae_ in children attending daycare centers: nationwide population-based study, South Korea 2014 and 2019.
Young June Choe YJ, et al.
Int J Infect Dis. 2021;111:328-332
https://doi.org/10.1016/j.ijid.2021.08.065

Case reports
------------
Seronegative neurobrucellosis -- do we need new neurobrucellosis criteria?
Papadopoulos VE, et al.
Int J Infect Dis. 2021;111:124-126
https://doi.org/10.1016/j.ijid.2021.08.038

Leprosy -- an unusual cause of a suspicious nodule on mammography.
Flis C, et al.
Int J Infect Dis. 2021;111:360-362
https://doi.org/10.1016/j.ijid.2021.08.068

Correspondence
--------------
The timing of antibiotic therapy and its impact on immunotherapy efficacy.
Poizeau F, et al.
Int J Infect Dis. 2021;111:99-99
https://doi.org/10.1016/j.ijid.2021.08.047

--
communicated by:
ProMED
<promed@promedmail.org>
See Also
New in IJID (09): September 2021: 20211007.8698901
New in IJID (08): August 2021: 20210907.8651803
New in IJID (07): July 2021 20210812.8580841
New in IJID (06): June 2021 20210722.8536790
New in IJID (05): May 2021 20210516.8364910
New in IJID (04): April 2021 120210421.8319851
New in IJID (03): March 2021 20210316.8250191
New in IJID (02): February 2021 20210210.8182520
New in IJID (01): January 2021 20210114.8102611
2020
---
New in IJID (12): December 2020 20201209.8005250
New in IJID (11): November 2020 20201117.7950604
New in IJID (10): October 2020 20201023.7884336
.................................................ep/may/sh
</body>
